Antidepressants SSRIs (e.g., Sertraline) common for treating depression and anxiety, may amplify nausea, a side effect already associated with semaglutide
Sam Sukkar, conducts a thorough health assessment and reviews your full medical history to ensure the medication is both safe and effective for you
Typically administered once a week, Semaglutide GLP-1 helps regulate appetite and facilitate weight loss by maintaining steady levels in your body
Reduced-frequency alternatives include 2 to 3 mg three times per week or 2 mg every other day, producing similar weekly exposure with fewer injections
The FDA will review the full meeting record After the meeting, the FDA can consider: The committees recommendations Written comments submitted to the public docket Public testimony presented during the meeting FDA staff evaluations Substance characterization and sourcing concerns Available human, animal, and laboratory research Additional regulatory or safety information The FDAs July 2026 briefing document states that the final determination may also be affected by issues that were not discussed during the public meeting